Experienced in Swallowing Difficulty

Jorg B. Schulz

Aachen, NW, DE 
Experienced in Swallowing Difficulty
Aachen, NW, DE 
OverviewLocationsClinical Research

Overview

Jorg Schulz practices in Aachen, Germany. Schulz is rated as an Experienced expert by MediFind in the treatment of Swallowing Difficulty. Their top areas of expertise are Friedreich Ataxia, Spinocerebellar Ataxia, Movement Disorders, Thrombectomy, and Deep Brain Stimulation.

Their clinical research consists of co-authoring 370 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 2 articles in the study of Swallowing Difficulty.

Locations

Aachen, NW, Germany
Other Locations
Juelich, NW, Germany
Schenefeld, SH 22869, Germany
Mainz, RP 55128, Germany
Berlin, BE, Germany
Hamburg, HH 20245, Germany
Karlsruhe, BW, Germany
Heidelberg, BW 69120, Germany
Hannover, NI, Germany
Goettingen, NI, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Patient Registry of the European Friedreich's Ataxia Consortium for Translational Studies (EFACTS)
Patient Registry of the European Friedreich's Ataxia Consortium for Translational Studies (EFACTS)
Enrollment Status: Completed
Publish Date: October 03, 2025
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy, Safety and Biomarker Effects of ALZ-801 in Subjects With Early Alzheimer's Disease and APOE4/4 Genotype
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy, Safety and Biomarker Effects of ALZ-801 in Subjects With Early Alzheimer's Disease and APOE4/4 Genotype
Enrollment Status: Completed
Publish Date: May 16, 2025
Intervention Type: Drug
Study Drug: ALZ-801
Study Phase: Phase 3
A Natural History Study to TRACK Brain and Spinal Cord Changes in Individuals with Friedreich Ataxia (TRACK-FA)
A Natural History Study to TRACK Brain and Spinal Cord Changes in Individuals with Friedreich Ataxia (TRACK-FA)
Enrollment Status: Active_not_recruiting
Publish Date: November 27, 2024
Intervention Type: Other
Solitaire™ With the Intention For Thrombectomy Plus Intravenous t-PA Versus DIRECT Solitaire™ Stent-retriever Thrombectomy in Acute Anterior Circulation Stroke
Solitaire™ With the Intention For Thrombectomy Plus Intravenous t-PA Versus DIRECT Solitaire™ Stent-retriever Thrombectomy in Acute Anterior Circulation Stroke
Enrollment Status: Completed
Publish Date: November 14, 2024
Intervention Type: Drug, Device
Study Phase: Not Applicable
View 3 Less Clinical Trials

369 Total Publications

Automated Deep Learning-based Segmentation of the Dentate Nucleus Using Quantitative Susceptibility Mapping MRI.
Automated Deep Learning-based Segmentation of the Dentate Nucleus Using Quantitative Susceptibility Mapping MRI.
Journal: Radiology. Artificial intelligence
Published: August 06, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Schulz's expertise for a condition
ConditionClose
View All 14 Advanced Conditions
View All 79 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile